15 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2022
-
01/2003 |
14 | oxidized low density lipoproteinIBA
05/2022
-
09/2005 |
13 | LipidsIBA
01/2019
-
11/2002 |
10 | LDL CholesterolIBA
01/2019
-
11/2002 |
7 | Ezetimibe (Zetia)FDA Link
01/2021
-
11/2006 |
7 | Glucose (Dextrose)FDA LinkGeneric
01/2017
-
01/2007 |
7 | Triglycerides (Triacylglycerol)IBA
01/2017
-
01/2003 |
6 | HDL CholesterolIBA
01/2017
-
01/2003 |
5 | Blood Glucose (Blood Sugar)IBA
05/2015
-
01/2002 |
5 | Niacin (Nicotinic Acid)FDA LinkGeneric
05/2015
-
04/2008 |
5 | CholesterolIBA
02/2015
-
06/2005 |
5 | Anti-Obesity Agents (Antiobesity Drugs)IBA
12/2010
-
01/2002 |
3 | Colesevelam Hydrochloride (Welchol)FDA Link
09/2014
-
11/2006 |
3 | Telmisartan (Micardis)FDA Link
06/2014
-
01/2013 |
3 | Hydrochlorothiazide (Esidrix)FDA LinkGeneric
06/2014
-
01/2013 |
3 | EnzymesIBA
05/2014
-
05/2003 |
3 | LDL Lipoproteins (beta Lipoproteins)IBA
04/2014
-
11/2002 |
3 | Lipoproteins (Lipoprotein)IBA
08/2012
-
10/2009 |
3 | Simvastatin (Zocor)FDA LinkGeneric
10/2009
-
01/2003 |
3 | Cannabinoid Receptor AntagonistsIBA
08/2007
-
03/2006 |
2 | 8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
05/2022
-
01/2021 |
2 | Proprotein Convertase 9IBA
01/2021
-
05/2015 |
2 | Bile Acids and Salts (Bile Acids)IBA
01/2021
-
09/2014 |
2 | ApolipoproteinsIBA
01/2021
-
10/2009 |
2 | evolocumabIBA
01/2019
-
06/2014 |
2 | Hormones (Hormone)IBA
03/2016
-
01/2006 |
2 | Insulin (Novolin)FDA Link
02/2015
-
08/2011 |
2 | SugarsIBA
10/2014
-
12/2010 |
2 | MK-0524IBA
08/2012
-
03/2010 |
2 | EstersIBA
10/2009
-
03/2008 |
2 | sibutramine (Meridia)FDA Link
08/2007
-
11/2006 |
2 | Orlistat (Xenical)FDA Link
08/2007
-
11/2006 |
2 | Neuropeptide YIBA
04/2007
-
01/2006 |
2 | trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA
04/2007
-
10/2006 |
2 | Nonesterified Fatty Acids (NEFA)IBA
11/2006
-
02/2004 |
1 | Insulin Glargine (Lantus)FDA Link
04/2024 |
1 | Biosimilar PharmaceuticalsIBA
04/2024 |
1 | salicylhydroxamic acid (SHAM)IBA
01/2023 |
1 | C-Reactive ProteinIBA
01/2021 |
1 | LiraglutideFDA Link
01/2017 |
1 | Hemoglobins (Hemoglobin)IBA
01/2017 |
1 | Trace Elements (Biometals)IBA
03/2016 |
1 | MineralsIBA
03/2016 |
1 | Proteins (Proteins, Gene)FDA Link
03/2016 |
1 | CarbohydratesIBA
03/2016 |
1 | FatsIBA
03/2016 |
1 | VitaminsIBA
03/2016 |
1 | Monoclonal AntibodiesIBA
05/2015 |
1 | bococizumabIBA
05/2015 |
1 | HDL-triglycerideIBA
02/2015 |
1 | Biomarkers (Surrogate Marker)IBA
10/2014 |
1 | Glycoproteins (Glycoprotein)IBA
04/2014 |
1 | Apoprotein(a) (Apolipoprotein (a))IBA
04/2014 |
1 | PlasminogenIBA
04/2014 |
1 | SymportersIBA
12/2013 |
1 | Sodium-Glucose Transporter 2 InhibitorsIBA
12/2013 |
1 | Naltrexone (ReVia)FDA LinkGeneric
12/2013 |
1 | SodiumIBA
12/2013 |
1 | Bupropion (Wellbutrin)FDA LinkGeneric
12/2013 |
1 | Antihypertensive Agents (Antihypertensives)IBA
01/2013 |
1 | HDL LipoproteinsIBA
08/2012 |
1 | IDL Lipoproteins (Lipoprotein, IDL)IBA
08/2012 |
1 | hydrochlorothiazide drug combination telmisartanIBA
07/2012 |
1 | GlucansIBA
08/2011 |
1 | Acetates (Acetic Acid Esters)FDA Link
05/2011 |
1 | 1- ((1- (3- acetoxy- 2,2- dimethylpropyl)- 7- chloro- 5- (2,3- dimethoxyphenyl)- 2- oxo- 1,2,3,5- tetrahydro- 4,1- benzoxazepin- 3- yl)acetyl)piperidine- 4- acetic acidIBA
05/2011 |
1 | Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA
05/2011 |